After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...

Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

Columnist Ben Hofmeister is now six months into first eliminating, then gradually reintroducing, foods to his diet to manage MS symptoms.

Teva Canada and Novartis Canada are collaborating to ensure continued access to Mayzent for people with active SPMS in Canada ...

BTK inhibitors such as tolebrutinib or evobrutinib work about as well as Aubagio at preventing relapses in MS, a review of ...

A higher adherence to a Mediterranean diet is linked to a lower risk of developing MS, particularly in nonsmokers and people ...

Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

Difficulty walking with MS is not just about physical limitations, but also emotions, stigma, and how others respond, a ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

AB Science has secured a patent in Japan, valid through February 2041, covering the use of masitinib for progressive forms of MS.

A brief, four-session stress management program helped ease symptoms of depression and anxiety and reduced stress in people ...